Haring-Layton MarDee 4
4 · Dare Bioscience, Inc. · Filed Mar 14, 2024
Insider Transaction Report
Form 4
Haring-Layton MarDee
Chief Accounting Officer
Transactions
- Award
Employee Stock Option (right to buy)
2024-03-12+290,000→ 290,000 totalExercise: $0.46Exp: 2034-03-12→ Common stock (290,000 underlying)
Footnotes (1)
- [F1]This stock option vests and becomes exercisable in 48 equal monthly installments commencing on the one-month anniversary of the grant date, subject to the reporting person's continuous service to the issuer.